Could CR mean cure?

被引:8
作者
Barlogie, Bart [1 ]
Crowley, John [1 ]
机构
[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
关键词
MULTIPLE-MYELOMA;
D O I
10.1182/blood-2011-05-350322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:483 / 483
页数:1
相关论文
共 8 条
  • [1] F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
    Bartel, Twyla B.
    Haessler, Jeff
    Brown, Tracy L. Y.
    Shaughnessy, John D., Jr.
    van Rhee, Frits
    Anaissie, Elias
    Alpe, Terri
    Angtuaco, Edgardo
    Walker, Ronald
    Epstein, Joshua
    Crowley, John
    Barlogie, Bart
    [J]. BLOOD, 2009, 114 (10) : 2068 - 2076
  • [2] Achievement of at Least Very Good Partial Response Is a Simple and Robust Prognostic Factor in Patients With Multiple Myeloma Treated With High-Dose Therapy: Long-Term Analysis of the IFM 99-02 and 99-04 Trials
    Harousseau, Jean-Luc
    Avet-Loiseau, Herve
    Attal, Michel
    Charbonnel, Catherine
    Garban, Frederic
    Hulin, Cyrille
    Michallet, Mauricette
    Facon, Thierry
    Garderet, Laurent
    Marit, Gerald
    Ketterer, Nicolas
    Lamy, Thierry
    Voillat, Laurent
    Guilhot, Francois
    Doyen, Chantal
    Mathiot, Claire
    Moreau, Philippe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) : 5720 - 5726
  • [3] Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols
    Hoering, Antje
    Crowley, John
    Shaughnessy, John D., Jr.
    Hollmig, Klaus
    Alsayed, Yazan
    Szymonifka, Jackie
    Waheed, Sarah
    Nair, Bijay
    Van Rhee, Frits
    Anaissie, Elias
    Barlogie, Bart
    [J]. BLOOD, 2009, 114 (07) : 1299 - 1305
  • [4] Long-term prognostic significance of response in multiple myeloma after stem cell transplantation
    Martinez-Lopez, Joaquin
    Blade, Joan
    Mateos, Maria-Victoria
    Grande, Carlos
    Alegre, Adrian
    Garcia-Larana, Jose
    Sureda, Anna
    de la Rubia, Javier
    Conde, Eulogio
    Martinez, Rafael
    de Arriba, Felipe
    Viguria, Maria C.
    Besalduch, Joan
    Cabrera, Rafael
    Gonzalez-San Miguel, Jose D.
    Luis Guzman-Zamudio, Jose
    Carmen Gomez del Castillo, Ma
    Ma Moraleda, Jose
    Garcia-Ruiz, Juan C.
    San Miguel, Jesus
    Jose Lahuerta, Juan
    [J]. BLOOD, 2011, 118 (03) : 529 - 534
  • [5] Current Trends in Autologous Stem-Cell Transplantation for Myeloma in the Era of Novel Therapies
    Moreau, Philippe
    Avet-Loiseau, Herve
    Harousseau, Jean-Luc
    Attal, Michel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (14) : 1898 - 1906
  • [6] A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
    Shaughnessy, John D.
    Zhan, Fenghuang
    Burington, Bart E.
    Huang, Yongsheng
    Colla, Simona
    Hanamura, Ichiro
    Stewart, James P.
    Kordsmeier, Bob
    Randolph, Christopher
    Williams, David R.
    Xiao, Yan
    Xu, Hongwei
    Epstein, Joshua
    Anaissie, Elias
    Krishna, Somashekar G.
    Cottler-Fox, Michele
    Hollmig, Klaus
    Mohiuddin, Abid
    Pineda-Roman, Mauricio
    Tricot, Guido
    van Rhee, Frits
    Sawyer, Jeffrey
    Alsayed, Yazan
    Walker, Ronald
    Zangari, Maurizio
    Crowley, John
    Barlogie, Bart
    [J]. BLOOD, 2007, 109 (06) : 2276 - 2284
  • [7] van Rhee F, 2010, WILLIAMS HEMATOLOGY, P1645
  • [8] Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications
    Walker, Ronald
    Barlogie, Bart
    Haessler, Jeffrey
    Tricot, Guido
    Anaissie, Elias
    Shaughnessy, John D., Jr.
    Epstein, Joshua
    van Hemert, Rudy
    Erdem, Eren
    Hoering, Antje
    Crowley, John
    Ferris, Ernest
    Hollmig, Klaus
    van Rhee, Frits
    Zangari, Maurizio
    Pineda-Roman, Mauricio
    Mohiuddin, Abid
    Yaccoby, Shmuel
    Sawyer, Jeffrey
    Angtuaco, Edgardo J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (09) : 1121 - 1128